Uso de terapia de reperfusão e mortalidade em mulheres com infarto agudo do miocárdio com supradesnivelamento do segmento ST: Estudo Victim

Abstract

Introduction: Myocardial reperfusion is a fundamental part of the treatment for STEMI and is responsible for reducing morbimortality in the affected patient. However, women often have lower reperfusion rates higher mortality rate. Objectives: To compare the use of reperfusion therapies and mortality in women and men with STEMI in Sergipe. Methods: This was a cross-sectional study with a quantitative approach using data from the VICTIM - Via Crucis Study for the Treatment of Myocardial Infarction. We evaluated patients with a diagnosis of STEMI admitted to the private hospitals and the public with capacity to perform PCI in Sergipe. The collection was carried out from December 2014 to Juner 2018. Results: A total of 878 patients diagnosed with STEMI were studied, of which 33.4% were women. Only 53.3% of the patients underwent myocardial reperfusion therapy (134 women versus 334 men). Fibrinolysis was performed in 2.3% of all patients (1.7% of women versus 2.6% of men, p = 0.422). In females, the primary PCI was significantly lower than in the opposite sex (44% versus 54.5%, p = 0.003) and the hospital mortality was higher (16.1% versus 6.7%, p <0.001). Conclusions: Women present, mean, lower rate and higher hospital size than men. In addition, the reperfusion rate in both sexes was low and there was underutilization of thrombolytics in the state. The inadequate approach of the patient with IAMCSST in the state of Sergipe is evident, and improvements in the state health system are necessary.